Myriad Genetics (MYGN) Total Debt Growth (3y) (2019 - 2024)
Myriad Genetics (MYGN) Total Debt Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 9.58% |
| 10 | Myriad Genetics | 283.91 Mn | 159.51 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -42.88% |
| Mar 31, 2024 | -36.90% |
| Dec 31, 2023 | -44.47% |
| Sep 30, 2023 | -44.72% |
| Jun 30, 2023 | -44.74% |
| Jun 30, 2021 | 142.50% |
| Mar 31, 2021 | 26.16% |
| Dec 31, 2020 | 25.69% |
| Sep 30, 2020 | 21.14% |
| Jun 30, 2020 | 0.16% |
| Mar 31, 2020 | -8.22% |
| Dec 31, 2019 | 3.85% |
| Sep 30, 2019 | 4.65% |